ASP Isotopes Inc. Common Stock logo

ASP Isotopes Inc. Common Stock

ASPI

NASDAQBasic MaterialsChemicals

Latest quote

$3.99

+$0.05 · +1.27%

Aug 21, 3:55 PM ET

ASPI company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

46

Fair Value

Momentum

21

Weakening

Sentiment

38

Bearish

Risk resilience

12

Extreme Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Industry
Chemicals
Sector
Basic Materials
Headquarters
US
CEO
Paul Elliot Mann
Listed since
Nov 10, 2022
Employees
271

Market position

Volume
3.43M
0.75× average
Average volume
4.58M
Average daily volume
Market cap
503.61M USD
Beta
3.62
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-3.04×
P/B (TTM)
1.85×
P/S (TTM)
16.32×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
18.32%
Operating margin
-312.31%
Net margin
-428.00%

Financial health

Debt / equity
1.02×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends419%-1101%-2621%-4141%Gross margin, FY2023: 32.09%Gross margin, FY2024: 38.59%Gross margin, FY2025: 14.28%Operating margin, FY2023: -3704.63%Operating margin, FY2024: -635.96%Operating margin, FY2025: -239.80%Net margin, FY2023: -3761.03%Net margin, FY2024: -780.26%Net margin, FY2025: -734.17%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2023 32.09%. Gross margin FY2024 38.59%. Gross margin FY2025 14.28%. Operating margin FY2023 -3704.63%. Operating margin FY2024 -635.96%. Operating margin FY2025 -239.80%. Net margin FY2023 -3761.03%. Net margin FY2024 -780.26%. Net margin FY2025 -734.17%.

Income trends

Revenue

23.85M USD+475.51%

Operating income

−57.19M USD-117.01%

Net income

−175.09M USD-441.51%
Income trends across reported periods43.74M USD−35.83M USD−115.41M USD−194.99M USDRevenue, FY2023: 433.03K USDRevenue, FY2024: 4.14M USDRevenue, FY2025: 23.85M USDOperating income, FY2021: −2.61M USDOperating income, FY2022: −5.1M USDOperating income, FY2023: −16.04M USDOperating income, FY2024: −26.35M USDOperating income, FY2025: −57.19M USDNet income, FY2021: −2.61M USDNet income, FY2022: −4.95M USDNet income, FY2023: −16.29M USDNet income, FY2024: −32.33M USDNet income, FY2025: −175.09M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2023 433.03K USD. Revenue FY2024 4.14M USD. Revenue FY2025 23.85M USD. Operating income FY2021 −2.61M USD. Operating income FY2022 −5.1M USD. Operating income FY2023 −16.04M USD. Operating income FY2024 −26.35M USD. Operating income FY2025 −57.19M USD. Net income FY2021 −2.61M USD. Net income FY2022 −4.95M USD. Net income FY2023 −16.29M USD. Net income FY2024 −32.33M USD. Net income FY2025 −175.09M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue23.85M USD4.14M USD433.03K USD
Cost of goods sold20.44M USD2.55M USD294.06K USD19.38K USD
Gross profit3.41M USD1.6M USD138.97K USD−19.38K USD
Research and development12.36M USD3.14M USD764.58K USD1.27M USD41.61K USD
Selling, general, and administrative48.24M USD24.81M USD15.42M USD3.83M USD2.55M USD
Operating expenses60.6M USD27.95M USD16.18M USD5.1M USD2.59M USD
Interest income6.79M USD1.24M USD9.07K USD3.38K USD115 USD
Interest expense575K USD258.87K USD118.55K USD
Depreciation and amortization1.91M USD471K USD37.43K USD72.57K USD19.38K USD
Operating income−57.19M USD−26.35M USD−16.04M USD−5.1M USD−2.61M USD
Net income−175.09M USD−32.33M USD−16.29M USD−4.95M USD−2.61M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
0%
0 beats, 4 misses, 4 met estimates
Average EPS surprise
-110.31%
8 comparable reports
Latest EPS result
-0.28
Estimate -0.17 · Miss by 64.71%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.05-0.4-0.76-1.11Q1 '25MissQ2 '25MetQ3 '25MetQ4 '25MetQ2 '26MissQ2 '26MetQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 31, 2025: actual -0.13, estimate -0.09, surprise -44.44%, Miss. Q2 2025, reported May 20, 2025: actual -0.12, estimate -0.12, surprise 0.00%, Met estimate. Q3 2025, reported Aug 14, 2025: actual -1.03, estimate -1.03, surprise 0.00%, Met estimate. Q4 2025, reported Nov 19, 2025: actual -0.15, estimate -0.15, surprise 0.00%, Met estimate. Q2 2026, reported Apr 10, 2026: actual -0.84, estimate -0.1, surprise -740.00%, Miss. Q2 2026, reported May 20, 2026: actual -0.06, estimate -0.06, surprise 0.00%, Met estimate. Q3 2026, reported Aug 14, 2026: actual -0.28, estimate -0.17, surprise -64.71%, Miss. Q4 2026, reported Nov 12, 2026: actual —, estimate -0.15, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates17.95M12.28M6.61M936.36KQ1 '25MetQ2 '25MissQ3 '25MissQ4 '25BeatQ2 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 31, 2025: actual 1.2M USD, estimate 1.2M USD, surprise 0.00%, Met estimate. Q2 2025, reported May 20, 2025: actual 1.1M USD, estimate 6.8M USD, surprise -83.80%, Miss. Q3 2025, reported Aug 14, 2025: actual 1.2M USD, estimate 1.6M USD, surprise -25.10%, Miss. Q4 2025, reported Nov 19, 2025: actual 4.89M USD, estimate 2.03M USD, surprise +140.78%, Beat. Q2 2026, reported Apr 10, 2026: actual 16.7M USD, estimate 2.03M USD, surprise +721.31%, Beat. Q2 2026, reported May 20, 2026: actual 4.18M USD, estimate 4.43M USD, surprise -5.57%, Miss. Q3 2026, reported Aug 14, 2026: actual 5.12M USD, estimate 5.67M USD, surprise -9.72%, Miss. Q4 2026, reported Nov 12, 2026: actual —, estimate 7.34M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$9.50

137.50% upside
Past 12 months12-month forecastHigh $15.00Average $9.50Low $4.50

ASPI peers

ETFs holding ASPI

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research ASPI

research.disclaimer